Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.0061 | 1 |
mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |